360 related articles for article (PubMed ID: 15994556)
21. The HLA-DRalpha chain is modified by polyubiquitination.
Lapaque N; Jahnke M; Trowsdale J; Kelly AP
J Biol Chem; 2009 Mar; 284(11):7007-16. PubMed ID: 19117940
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitination of HLA-DO by MARCH family E3 ligases.
Jahnke M; Trowsdale J; Kelly AP
Eur J Immunol; 2013 May; 43(5):1153-61. PubMed ID: 23400868
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids.
Shimizu Y; Okuda-Shimizu Y; Hendershot LM
Mol Cell; 2010 Dec; 40(6):917-26. PubMed ID: 21172657
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1).
Corcoran K; Jabbour M; Bhagwandin C; Deymier MJ; Theisen DL; Lybarger L
J Biol Chem; 2011 Oct; 286(43):37168-80. PubMed ID: 21896490
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus.
Thomas M; Wills M; Lehner PJ
Biochem Soc Trans; 2008 Jun; 36(Pt 3):459-63. PubMed ID: 18481981
[TBL] [Abstract][Full Text] [Related]
26. Contribution of lysine 11-linked ubiquitination to MIR2-mediated major histocompatibility complex class I internalization.
Goto E; Yamanaka Y; Ishikawa A; Aoki-Kawasumi M; Mito-Yoshida M; Ohmura-Hoshino M; Matsuki Y; Kajikawa M; Hirano H; Ishido S
J Biol Chem; 2010 Nov; 285(46):35311-9. PubMed ID: 20833710
[TBL] [Abstract][Full Text] [Related]
27. The yeast Npi1/Rsp5 ubiquitin ligase lacking its N-terminal C2 domain is competent for ubiquitination but not for subsequent endocytosis of the gap1 permease.
Springael JY; De Craene JO; André B
Biochem Biophys Res Commun; 1999 Apr; 257(2):561-6. PubMed ID: 10198251
[TBL] [Abstract][Full Text] [Related]
28. β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination.
McElrath CJ; Benzow S; Zhuo Y; Marchese A
J Biol Chem; 2023 Dec; 299(12):105474. PubMed ID: 37981209
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of MHC class II expression and immune responses by c-MIR.
Ohmura-Hoshino M; Matsuki Y; Aoki M; Goto E; Mito M; Uematsu M; Kakiuchi T; Hotta H; Ishido S
J Immunol; 2006 Jul; 177(1):341-54. PubMed ID: 16785530
[TBL] [Abstract][Full Text] [Related]
30. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.
Furukawa M; Xiong Y
Mol Cell Biol; 2005 Jan; 25(1):162-71. PubMed ID: 15601839
[TBL] [Abstract][Full Text] [Related]
31. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
32. Human and viral membrane-associated E3 ubiquitin ligases MARCH1 and MIR2 recognize different features of CD86 to downregulate surface expression.
Trenker R; Wu X; Nguyen JV; Wilcox S; Rubin AF; Call ME; Call MJ
J Biol Chem; 2021 Jul; 297(1):100900. PubMed ID: 34157285
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins.
Bartee E; Mansouri M; Hovey Nerenberg BT; Gouveia K; Früh K
J Virol; 2004 Feb; 78(3):1109-20. PubMed ID: 14722266
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments.
Lorenzo ME; Jung JU; Ploegh HL
J Virol; 2002 Jun; 76(11):5522-31. PubMed ID: 11991980
[TBL] [Abstract][Full Text] [Related]
35. Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines.
Lee JN; Gong Y; Zhang X; Ye J
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4958-63. PubMed ID: 16549805
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitination of substrates by esterification.
Wang X; Herr RA; Hansen TH
Traffic; 2012 Jan; 13(1):19-24. PubMed ID: 21883762
[TBL] [Abstract][Full Text] [Related]
37. A novel family of membrane-bound E3 ubiquitin ligases.
Ohmura-Hoshino M; Goto E; Matsuki Y; Aoki M; Mito M; Uematsu M; Hotta H; Ishido S
J Biochem; 2006 Aug; 140(2):147-54. PubMed ID: 16954532
[TBL] [Abstract][Full Text] [Related]
38. Cellular functions and molecular mechanisms of non-lysine ubiquitination.
McClellan AJ; Laugesen SH; Ellgaard L
Open Biol; 2019 Sep; 9(9):190147. PubMed ID: 31530095
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases.
Lehner PJ; Hoer S; Dodd R; Duncan LM
Immunol Rev; 2005 Oct; 207():112-25. PubMed ID: 16181331
[TBL] [Abstract][Full Text] [Related]
40. The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.
Kim BJ; Chan DW; Jung SY; Chen Y; Qin J; Wang Y
Cell Rep; 2017 May; 19(9):1758-1766. PubMed ID: 28564596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
